Press releaseGlobe Newswire
Hims & Hers Health
HIMS · NYSE
$29.21+$1.06 (+3.77%)TodayMarket closed ·
Prev close $28.15
Latest news
- Press releasePRNewswire
What's Next for Hims & Hers Health, Inc. Shareholders After 14.73% Stock Drop? Glancy Prongay Wolke & Rotter LLP Explains Securities Fraud Class Action Lead Plaintiff Deadline
- Press releasePRNewswire
Hims & Hers Health (NYSE: HIMS) Facing Securities Class Action After FTC Lawsuit Reveal Drives Stock Sharply Lower
- Press releaseNewsfile
Kaplan Fox Encourages Hims & Hers Health, Inc. (HIMS) Investors With Significant Losses to Take Action Before the November 2, 2026 Lead Plaintiff Deadline
- Press releaseNewsfile
HIMS DEADLINE: ROSEN, A TOP-RANKED LAW FIRM, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important November 2 Deadline in Securities Class Action - HIMS
- Press releasePRNewswire
Robbins LLP Reminds HIMS Investors of the Pending Class Action Lawsuit; Harmed Investors Should Contact the Firm Before November 2, 2026, for Information About Leading the Lawsuit Against Hims & Hers Health, Inc.
- Press releasePRNewswire
What Does Hims & Hers Health, Inc.'s 14.73% Stock Drop Mean for Investors? The Law Offices of Howard G. Smith Outlines Securities Fraud Class Action Lead Plaintiff Deadline
- Press releaseGlobe Newswire
HIMS DEADLINE: ROSEN, LEADING INVESTOR RIGHTS COUNSEL, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important November 2 Deadline in Securities Class Action - HIMS
- Press releaseGlobe Newswire
Deadline Alert: Hims & Hers Health, Inc. Investors Have Until November 2, 2026 to Seek Lead Plaintiff Role in Securities Fraud Class Action, Glancy Prongay Wolke & Rotter LLP Reminds
- Press releaseGlobe Newswire
HIMS 2-WEEK DEADLINE ALERT: Hims & Hers Health Faces Securities Fraud Class Action, Investors with Losses Encouraged to Contact Hagens Berman
- Press releaseGlobe Newswire
Kaplan Fox Notifies Hims & Hers Health, Inc. (NYSE: HIMS) Investors of a Securities Class Action Lawsuit – Deadline is November 2, 2026
- Press releaseNewsfile
Kaplan Fox Advises Hims & Hers Health, Inc. (NYSE) Investors With Losses to Contact the Firm Ahead of the November 2, 2026 Deadline
- Press releasePRNewswire
HIMS Deadline: HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit
- Press releasePRNewswire
Hims & Hers Health Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Hims & Hers Health, Inc. - HIMS
- Press releaseNewsfile
Kaplan Fox Alerts Hims & Hers Health, Inc. (HIMS) Investors of a Securities Class Action Filed in Federal Court - Deadline is November 2, 2026
- Press releaseGlobe Newswire
Kaplan Fox Announces a Securities Class Action Against Hims & Hers Health, Inc. (NYSE: HIMS) – Lead Plaintiff Deadline is November 2, 2026
- Press releaseGlobe Newswire
Bragar Eagel & Squire, P.C. Reminds Hims & Hers Health, Inc. Investors of the Upcoming Lead Plaintiff Deadline and Urges Investors to Contact the Firm
- Press releaseNewsfile
Kaplan Fox Encourages Hims & Hers Health, Inc. (HIMS) Investors to Learn About the Securities Class Action Ahead of the November 2, 2026 Deadline
- Press releaseGlobe Newswire
INVESTOR DEADLINE: Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Before November 2, 2026 Deadline, Robbins Geller Rudman & Dowd LLP Announces - HIMS
- Press releaseGlobe Newswire
Robbins LLP Reminds HIMS Investors of the Pending Class Action Lawsuit; Harmed Investors Should Contact the Firm for Information About Leading the Class Action
- Press releasePRNewswire
HIMS INVESTOR ALERT: Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - November 2, 2026 Deadline
- Press releaseGlobe Newswire
Hims & Hers Health (NYSE: HIMS) Faces Securities Fraud Class Action After FTC Lawsuit Reveal Drives Stock Sharply Lower
- Press releaseGlobe Newswire
Deadline Alert: Hims & Hers Health, Inc. (HIMS) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
- Press releaseNewsfile
Kaplan Fox Notifies Hims & Hers Health, Inc. (HIMS) Investors That Time Is Running Out to Lead the Securities Class Action - Deadline November 2, 2026
- Press releaseGlobe Newswire
Portnoy Law Firm Announces Class Action on Behalf of Hims & Hers Health, Inc. Investors
- Press releaseGlobe Newswire
Kaplan Fox Encourages Investors of Hims & Hers Health, Inc. (NYSE: HIMS) to Act Ahead of the Lead Plaintiff Deadline on November 2, 2026
- Press releasePRNewswire
Shareholders who lost money in shares of acquired Hims & Hers Health, Inc. (NYSE: HIMS) should contact Wolf Haldenstein Immediately
- News
10 Health Care Stocks With Whale Alerts In Today’s Session
- News
10 Health Care Stocks With Whale Alerts In Today’s Session
- News
10 Health Care Stocks Whale Activity In Today’s Session
- Press releaseGlobe Newswire
DEADLINE ALERT for HYLN, HIMS, UNCY, TBLA: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions
- News
8 Health Care Stocks Whale Activity In Today’s Session
- NewsVandana Singh
Fraudulent Weight Loss Drugs: FDA Warns Against Mislabeled GLP-1 Medications
- Press releasePRNewswire
Uniphore Launches Marketing AI to Usher in New Era: NYSE Content Update
- NewsPriya Nigam
Hims & Hers Health: Investments Necessary For Long-Term Incremental Growth, Says Bullish Analyst
- NewsKaustubh Bagalkote
Why Is Hims & Hers Health Stock Falling Tuesday?
- NewsAvi Kapoor
OppFi Posts Downbeat Q2 Earnings, Joins Upwork, Rocket Lab And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session
- NewsShivdeep Dhaliwal
Rocket Lab USA, Hims & Hers, AST SpaceMobile, Archer Aviation and Plug Power: Why These 5 Stocks Are on Investors' Radars Today
- NewsErica Kollmann
Hims & Hers Shares Drop After Mixed Q2 Earnings — Details
- News
Hims & Hers Health Q2 EPS $(0.37) Misses $(0.03) Estimate, Sales $753.214M Beat $699.889M Estimate
- NewsDylan Berman
Hims & Hers Stock Missed Estimates Last Quarter — Can It Turn the Page Tonight?
- NewsAvi Kapoor
Hims & Hers Health Likely To Report Q2 Loss; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
- NewsChris Katje
EXCLUSIVE: Top 12 Most-Searched Tickers On Benzinga Pro In March – Where Do Tesla, Nvidia, Micron Stocks Rank?
- NewsAvi Kapoor
Crude Oil Rises Around 4%; Xenon Pharmaceuticals Shares Surge
- NewsChris Katje
EXCLUSIVE: Top 12 Most-Searched Tickers On Benzinga Pro In February — Where Do Tesla, Nvidia, Palantir Stocks Rank?
- NewsAvi Kapoor
Gold Gains Over 2%; Sally Beauty Earnings Top Views
- NewsAvi Kapoor
This Netflix Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
- NewsChris Katje
EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In 2025 – Where Do Tesla, Nvidia, Palantir, Apple Stocks Rank?
- NewsChandrima Sanyal
Hims & Hers Powers YieldMax's Latest Options-Based Income ETF
- NewsChris Katje
EXCLUSIVE: August's 20 Most-Searched Tickers On Benzinga Pro – Where Do Opendoor, Palantir, BitMine Immersion, Apple Stock Rank?
- NewsChris Katje
EXCLUSIVE: July's 20 Most-Searched Tickers On Benzinga Pro — Where Do Opendoor, Nvidia, Apple Stock Rank?
- NewsChris Katje
EXCLUSIVE: 2025's First Half Most-Searched Tickers On Benzinga Pro — Where Do Nvidia, Tesla, Apple Stock Rank?
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.